After Regeneron Chief Scientific Officer George Yancopoulos, M.D., Ph.D., spent more than 25 minutes waxing about the company ...
High and low levels of high-density lipoprotein and a novel single-nucleotide polymorphism were found to be associated with ...
“Common conditions in older people include presbyopia (difficulty focusing on near tasks), cataracts (clouding of the lens), ...
The following is a summary of “Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the ...
PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces it has submitted a ...
For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While ...
About AXPAXLI AXPAXLIâ„¢ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...
SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects millions but has no medical cure.
SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.